Blocking VCAM-1 ameliorates hypertensive cardiac remodeling by impeding macrophage infiltration
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blocking VCAM-1 ameliorates hypertensive cardiac remodeling by impeding macrophage infiltration
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-17
DOI
10.3389/fphar.2022.1058268
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
- (2022) Liangqingqing Yin et al. Frontiers in Pharmacology
- VCAM-1 as a predictor biomarker in cardiovascular disease
- (2021) Mayarling Francisca Troncoso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice
- (2020) Yun-Long Zhang et al. HYPERTENSION
- Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction
- (2019) Alberto Aimo et al. JACC-Heart Failure
- CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration
- (2018) Lei Wang et al. EUROPEAN HEART JOURNAL
- Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Naturally occurring cell adhesion inhibitors
- (2018) Satoshi Takamatsu Journal of Natural Medicines
- Mechanisms of physiological and pathological cardiac hypertrophy
- (2018) Michinari Nakamura et al. Nature Reviews Cardiology
- Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline
- (2018) Kirsten S. Dorans et al. Journal of the American Heart Association
- Effect of Losartan on Mitral Valve Changes After Myocardial Infarction
- (2017) Philipp E. Bartko et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular DysfunctionClinical Perspective
- (2016) Lei Wang et al. CIRCULATION
- Physiological and pathological cardiac hypertrophy
- (2016) Ippei Shimizu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Inflammation and metabolic dysfunction: links to cardiovascular diseases
- (2012) Annika Taube et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The Progression of Hypertensive Heart Disease
- (2011) Mark H. Drazner CIRCULATION
- Vascular Cell Adhesion Molecule-1 Expression and Signaling During Disease: Regulation by Reactive Oxygen Species and Antioxidants
- (2010) Joan M. Cook-Mills et al. ANTIOXIDANTS & REDOX SIGNALING
- Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation
- (2010) Hugo Verdejo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice
- (2009) Katsuhisa Matsuura et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now